SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0001193125-23-213538
Filing Date
2023-08-15
Accepted
2023-08-15 17:15:26
Documents
1

Document Format Files

Seq Description Document Type Size
1 SC 13D/A d480893dsc13da.htm SC 13D/A 28329
  Complete submission text file 0001193125-23-213538.txt   29702
Mailing Address 3060 PEGASUS PARK DRIVE BUILDING 6 DALLAS TX 75247
Business Address 3060 PEGASUS PARK DRIVE BUILDING 6 DALLAS TX 75247 (310) 618-6994
Forte Biosciences, Inc. (Subject) CIK: 0001419041 (see all company filings)

IRS No.: 261243872 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-89959 | Film No.: 231175750
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O PFENEX INC. 10790 ROSELLE STREET SAN DIEGO CA 92121
Business Address
Wagner Paul A. (Filed by) CIK: 0001612842 (see all company filings)

Type: SC 13D/A